Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis

Journal of Molecular and Cellular Cardiology

Volumn 60, Issue 1, 2013, Pages 68-71

  Zhou, Junlan ^a   Cheng, Min ^b   Wu, Min ^b   Boriboun, Chan ^a   Jujo, Kentaro ^a   Xu, Shiyue ^a   Zhao, Ting C ^c   Tang, Yao Liang ^d   Kishore, Raj ^a   Qin, Gangjian ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Angiogenesis; E2F; Endothelial cells; Ischemia; Proliferation

Indexed keywords

TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F3;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIUM CELL; ENZYME SPECIFICITY; GENE EXPRESSION; HINDLIMB; ISCHEMIA; LASER DOPPLER FLOWMETRY; LEG ISCHEMIA; LIMB NECROSIS; MALE; MOUSE; NECROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TOE NECROSIS; VASCULAR ENDOTHELIUM;

ANIMALS; E2F2 TRANSCRIPTION FACTOR; E2F3 TRANSCRIPTION FACTOR; ENDOTHELIAL CELLS; G1 PHASE; HINDLIMB; ISCHEMIA; MICE; MICE, MUTANT STRAINS; NEOVASCULARIZATION, PATHOLOGIC; S PHASE;

MUS;

EID: 84877302340     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.04.009     Document Type: Article

References (15)

1. Qin G., Losordo D.W. E2F transcription factors in cardiovascular physiology. Control of cellular physiology by E2F transcription factors 2008, 341-366. Research Signpost, Kerala. K. Yoshida (Ed.).
2. Dzau V.J., Braun-Dullaeus R.C., Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 2002, 8:1249-1256.
3. Alexander J.H., Hafley G., Harrington R.A., Peterson E.D., Ferguson T.B., Lorenz T.J., et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 2005, 294:2446-2454.
4. Giangrande P.H., Zhang J., Tanner A., Eckhart A.D., Rempel R.E., Andrechek E.R., et al. Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia. Proc Natl Acad Sci U S A 2007, 104:12988-12993.
5. Chen H.-Z., Tsai S.-Y., Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 2009, 9:785-797.
6. Qin G., Kishore R., Dolan C.M., Silver M., Wecker A., Luedemann C.N., et al. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc Natl Acad Sci U S A 2006, 103:11015-11020.
7. Wu L., Timmers C., Maiti B., Saavedra H.I., Sang L., Chong G.T., et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 2001, 414:457-462.
8. Qin G., Ii M., Silver M., Wecker A., Bord E., Ma H., et al. Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J Exp Med 2006, 203:153-163.
9. Zhou J., Zhu Y., Cheng M., Dinesh D., Thorne T., Poh K.K., et al. Regulation of vascular contractility and blood pressure by the E2F2 transcription factor. Circulation 2009, 120:1213-1221.
10. Humbert P.O., Verona R., Trimarchi J.M., Rogers C., Dandapani S., Lees J.A. E2f3 is critical for normal cellular proliferation. Genes Dev 2000, 14:690-703.
11. DeGregori J., Johnson D.G. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 2006, 6:739-748.
12. Ebelt H., Zhang Y., Kampke A., Xu J., Schlitt A., Buerke M., et al. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo. Cardiovasc Res 2008, 80:219-226.
13. Saavedra H.I., Wu L., de Bruin A., Timmers C., Rosol T.J., Weinstein M., et al. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ 2002, 13:215-225.
14. Trimarchi J.M., Lees J.A. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002, 3:11-20.
15. Ebelt H., Hufnagel N., Neuhaus P., Neuhaus H., Gajawada P., Simm A., et al. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis. Circ Res 2005, 96:509-517.